Danaher Return on Tangible Equity 2010-2025 | DHR
Current and historical return on tangible equity values for Danaher (DHR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Danaher Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $3.77B | $-9.69B | -37.30% |
| 2024-12-31 | $3.90B | $-9.52B | -41.07% |
| 2024-09-30 | $3.89B | $-10.72B | -41.71% |
| 2024-06-30 | $4.20B | $-10.45B | -52.33% |
| 2024-03-31 | $4.40B | $-7.29B | -61.04% |
| 2023-12-31 | $4.74B | $-8.86B | -63.44% |
| 2023-09-30 | $5.87B | $-5.53B | -83.77% |
| 2023-06-30 | $6.30B | $-7.17B | -74.63% |
| 2023-03-31 | $6.85B | $-8.35B | -68.21% |
| 2022-12-31 | $7.10B | $-7.01B | -58.88% |
| 2022-09-30 | $6.64B | $-11.22B | -44.19% |
| 2022-06-30 | $6.21B | $-13.58B | -35.45% |
| 2022-03-31 | $6.29B | $-16.45B | -36.06% |
| 2021-12-31 | $6.27B | $-18.85B | -36.78% |
| 2021-09-30 | $5.72B | $-21.15B | -34.54% |
| 2021-06-30 | $5.45B | $-13.34B | -35.00% |
| 2021-03-31 | $4.60B | $-14.84B | -27.71% |
| 2020-12-31 | $3.51B | $-16.93B | -19.33% |
| 2020-09-30 | $3.57B | $-17.15B | -24.63% |
| 2020-06-30 | $3.37B | $-17.40B | -30.36% |
| 2020-03-31 | $3.19B | $-21.17B | -39.48% |
| 2019-12-31 | $2.94B | $-2.18B | -68.71% |
| 2019-09-30 | $2.43B | $-3.68B | -49.68% |
| 2019-06-30 | $2.45B | $-5.29B | -37.56% |
| 2019-03-31 | $2.41B | $-5.98B | -30.48% |
| 2018-12-31 | $2.65B | $-4.64B | -29.89% |
| 2018-09-30 | $2.76B | $-10.16B | -26.75% |
| 2018-06-30 | $2.67B | $-10.88B | -25.29% |
| 2018-03-31 | $2.55B | $-9.82B | -23.73% |
| 2017-12-31 | $2.49B | $-10.44B | -22.03% |
| 2017-09-30 | $2.38B | $-11.10B | -20.11% |
| 2017-06-30 | $2.20B | $-11.68B | -19.61% |
| 2017-03-31 | $2.30B | $-12.04B | -20.66% |
| 2016-12-31 | $2.55B | $-12.57B | -22.85% |
| 2016-09-30 | $2.50B | $-8.62B | -25.00% |
| 2016-06-30 | $3.51B | $-11.34B | -31.21% |
| 2016-03-31 | $3.55B | $-12.17B | -42.39% |
| 2015-12-31 | $3.36B | $-7.80B | -61.14% |
| 2015-09-30 | $3.33B | $-13.64B | -99.01% |
| 2015-06-30 | $2.61B | $0.14B | 581.39% |
| 2015-03-31 | $2.59B | $-0.68B | 387.00% |
| 2014-12-31 | $2.60B | $0.72B | 258.41% |
| 2014-09-30 | $2.73B | $1.62B | 314.15% |
| 2014-06-30 | $2.64B | $1.02B | 1234.58% |
| 2014-03-31 | $2.58B | $0.67B | -674.85% |
| 2013-12-31 | $2.70B | $0.17B | -272.36% |
| 2013-09-30 | $2.54B | $-1.00B | -148.20% |
| 2013-06-30 | $2.49B | $-1.37B | -123.55% |
| 2013-03-31 | $2.47B | $-1.76B | -104.87% |
| 2012-12-31 | $2.39B | $-2.72B | -93.71% |
| 2012-09-30 | $2.33B | $-2.21B | -86.16% |
| 2012-06-30 | $2.31B | $-2.74B | -73.64% |
| 2012-03-31 | $2.36B | $-2.54B | -66.40% |
| 2011-12-31 | $2.17B | $-3.34B | -76.22% |
| 2011-09-30 | $2.08B | $-3.91B | -103.94% |
| 2011-06-30 | $2.20B | $-4.40B | -197.48% |
| 2011-03-31 | $1.92B | $0.25B | -678.80% |
| 2010-12-31 | $1.79B | $0.07B | -252.93% |
| 2010-09-30 | $1.59B | $-0.38B | -169.16% |
| 2010-06-30 | $1.29B | $-1.08B | -118.65% |
| 2010-03-31 | $1.21B | $-1.45B | -106.40% |
| 2009-12-31 | $1.15B | $-0.84B | -97.92% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $136.013B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS Health (CVS) | United States | $78.381B | 9.74 |
| Elevance Health (ELV) | United States | $62.395B | 8.39 |
| Cencora (COR) | United States | $56.765B | 19.75 |
| DiDi Global (DIDIY) | China | $26.874B | 28.55 |
| Labcorp Holdings (LH) | United States | $20.399B | 16.55 |
| Natera (NTRA) | United States | $18.966B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.991B | 0.00 |
| CochLear (CHEOY) | Australia | $13.143B | 0.00 |
| Solventum (SOLV) | United States | $12.678B | 13.42 |
| ICON (ICLR) | Ireland | $11.592B | 10.78 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| Viatris (VTRS) | United States | $10.422B | 3.58 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| Medpace Holdings (MEDP) | United States | $8.964B | 23.81 |
| Sonic Healthcare (SKHHY) | Australia | $8.852B | 0.00 |
| HealthEquity (HQY) | United States | $8.449B | 37.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.680B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.587B | 14.87 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.918B | 28.96 |
| BrightSpring Health Services (BTSG) | United States | $3.506B | 32.17 |
| Sotera Health (SHC) | United States | $3.139B | 17.84 |
| Surgery Partners (SGRY) | United States | $2.861B | 37.20 |
| Concentras Parent (CON) | United States | $2.507B | 14.49 |
| Organon (OGN) | United States | $2.459B | 2.61 |
| Alignment Healthcare (ALHC) | United States | $2.455B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.222B | 85.57 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| PACS (PACS) | United States | $1.823B | 0.00 |
| Premier (PINC) | United States | $1.725B | 13.09 |
| GoodRx Holdings (GDRX) | United States | $1.672B | 33.43 |
| Ardent Health (ARDT) | United States | $1.589B | 6.77 |
| Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.277B | 438.00 |
| Establishment Labs Holdings (ESTA) | $1.202B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.080B | 8.22 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.878B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.759B | 7.10 |
| CareDx (CDNA) | United States | $0.663B | 10.36 |
| Nutex Health (NUTX) | United States | $0.632B | 9.57 |
| So-Young (SY) | China | $0.595B | 0.00 |
| SBC Medicals (SBC) | United States | $0.585B | 0.00 |
| Embecta (EMBC) | United States | $0.572B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| LifeMD (LFMD) | United States | $0.479B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.402B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.12 |
| Oncology Institute (TOI) | United States | $0.312B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.297B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.146B | 0.00 |
| DocGo (DCGO) | United States | $0.146B | 23.83 |
| Sera Prognostics (SERA) | United States | $0.110B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| KindlyMD (NAKA) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| ModivCare (MODV) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |